Biosimilar Newsletter Archive

1. 04.15.21 -- The Biosimilar Leadership Playbook: 5 Tips For Success 4/15/2021
   04/15/21 Biosimilar Development Newsletter
2. 04.14.21 -- Accelerate Viral Detection From Weeks To Days 4/14/2021
   04/14/21 Biosimilar Development Newsletter
3. 04.11.21 -- Biosimilar Education Across Europe: The Right Message 4/11/2021
   04/11/21 Biosimilar Development Newsletter
4. 04.08.21 -- Biosimilar Education Across Europe: The Right Message 4/8/2021
   04/08/21 Biosimilar Development Newsletter
5. 04.07.21 -- Listen Now: Antiviral Conjugates, Peptides, Biopharma Funding Success 4/7/2021
   04/07/21 Biosimilar Development Newsletter
6. 04.01.21 -- Subcutaneous Infliximab Across Indications: U.S. Impact 4/1/2021
   04/01/21 Biosimilar Development Newsletter
7. 03.29.21 -- Scalable Manufacturing Of Adeno Viral Vector For Gene Therapy 3/29/2021
   03/29/21 Biosimilar Development Newsletter
8. 03.25.21 -- Defining Subcutaneous Infliximab's U.S. Potential 3/25/2021
   03/25/21 Biosimilar Development Newsletter
9. 03.18.21 -- Biosimilar Regulatory And Legislative Actions Set Tone For 2021 3/18/2021
   03/18/21 Biosimilar Development Newsletter
10. 03.11.21 -- The Past, Present, And Future Of Biosimilar Manufacturing 3/11/2021
    03/11/21 Biosimilar Development Newsletter